Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
28.19
+1.53 (5.74%)
At close: May 1, 2026, 4:00 PM EDT
27.75
-0.44 (-1.56%)
After-hours: May 1, 2026, 5:06 PM EDT
Forte Biosciences Analyst Ratings
Total Analysts
3
Consensus Rating
Strong Buy
Price Target
$67.00
Upside
+137.67%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $65 | Buy | Initiates | $65 | +130.58% | Nov 25, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $61 | Strong Buy | Maintains | $61 | +116.39% | Nov 17, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $75 | Strong Buy | Initiates | $75 | +166.05% | Aug 18, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $61 | Strong Buy | Maintains | $61 | +116.39% | Aug 15, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $61 | Strong Buy | Maintains | $61 | +116.39% | Jun 24, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $64 → $61 | Strong Buy | Maintains | $64 → $61 | +116.39% | Apr 1, 2025 |
| TD Cowen | TD Cowen | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Jan 21, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $64 | Strong Buy | Maintains | $64 | +127.03% | Dec 4, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $3 → $64 | Strong Buy | Maintains | $3 → $64 | +127.03% | Nov 15, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $75 | Strong Buy | Maintains | $75 | +166.05% | Aug 19, 2024 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates $100 | Strong Buy | Initiates | $100 | +254.74% | May 30, 2024 |
| Ladenburg Thalmann | Ladenburg Thalmann | Hold → Strong Buy Upgrades $69 | Hold → Strong Buy | Upgrades | $69 | +143.88% | Apr 8, 2024 |
| Chardan Capital | Chardan Capital | Strong Sell → Hold Upgrades $100 → $88 | Strong Sell → Hold | Upgrades | $100 → $88 | +210.39% | Sep 20, 2021 |
| Brookline Capital | Brookline Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 3, 2021 |
| Chardan Capital | Chardan Capital | Strong Buy → Strong Sell Downgrades $100 | Strong Buy → Strong Sell | Downgrades | $100 | +254.74% | Sep 3, 2021 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 3, 2021 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.